Pharma-Bio Serv, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Dorado, PR
SEC filing record 1 source field available
Fiscal year end
31 October
Pharma-Bio Serv, Inc. has filed 524 SEC EDGAR filings since 24 Sep 2004

SEC filing history

Showing 201-225 of 373 matching filings.

Per page
25
Current page
9
NT 10-K File 000-50956

NT 10-K

Filing date
31 Jan 2017
Reporting date
31 Oct 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50956

CURRENT REPORT

Filing date
30 Jan 2017
Reporting date
30 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50956

CURRENT REPORT

Filing date
20 Jan 2017
Reporting date
17 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Jan 2017
Reporting date
15 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Jan 2017
Reporting date
10 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Jan 2017
Reporting date
10 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Jan 2017
Reporting date
10 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Jan 2017
Reporting date
10 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Jan 2017
Reporting date
01 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Jan 2017
Reporting date
29 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Jan 2017
Reporting date
01 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Jan 2017
Reporting date
01 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
21 Dec 2016
Reporting date
19 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
21 Dec 2016
Reporting date
19 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-50956

QUARTERLY REPORT

Filing date
14 Sep 2016
Reporting date
31 Jul 2016
Next action
Verify source filing
8-K File 000-50956

CURRENT REPORT

Filing date
14 Sep 2016
Reporting date
14 Sep 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50956

CURRENT REPORT

Filing date
14 Jun 2016
Reporting date
14 Jun 2016
Next action
Verify source filing
10-Q File 000-50956

QUARTERLY REPORT

Filing date
14 Jun 2016
Reporting date
30 Apr 2016
Next action
Verify source filing
8-K File 000-50956

CURRENT REPORT

Filing date
08 Jun 2016
Reporting date
08 Jun 2016
Next action
Verify source filing
8-K File 000-50956

CURRENT REPORT

Filing date
18 May 2016
Reporting date
13 May 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-50956

INFORMATION REQUIRED IN PROXY STATEMENT

Filing date
13 Apr 2016
Reporting date
06 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50956

CURRENT REPORT

Filing date
16 Mar 2016
Reporting date
16 Mar 2016
Next action
Verify source filing
10-Q File 000-50956

QUARTERLY REPORT

Filing date
16 Mar 2016
Reporting date
31 Jan 2016
Next action
Verify source filing
10-K/A File 000-50956

ANNUAL REPORT AMENDMENT

Filing date
29 Feb 2016
Reporting date
31 Oct 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50956

CURRENT REPORT

Filing date
29 Jan 2016
Reporting date
29 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .